Found: 10
Select item for more details and to access through your institution.
Decoding non-canonical mRNA decay by the endoplasmic-reticulum stress sensor IRE1α.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-27597-7
- By:
- Publication type:
- Article
T cell‐dependent bispecific antibodies alter organ‐specific endothelial cell–T cell interaction.
- Published in:
- EMBO Reports, 2023, v. 24, n. 3, p. 1, doi. 10.15252/embr.202255532
- By:
- Publication type:
- Article
Validating Immunohistochemistry Assay Specificity in Investigative Studies: Considerations for a Weight of Evidence Approach.
- Published in:
- Veterinary Pathology, 2021, v. 58, n. 5, p. 829, doi. 10.1177/0300985820960132
- By:
- Publication type:
- Article
Intelectin-1 is a prominent protein constituent of pathologic mucus associated with eosinophilic airway inflammation in asthma.
- Published in:
- 2014
- By:
- Publication type:
- Letter
lntelectin-1 Is a Prominent Protein Constituent of Pathologic Mucus Associated with Eosinophilic Airway Inflammation in Asthma.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2014, v. 189, n. 8, p. 1005, doi. 10.1164/rccm.201312-2220le
- By:
- Publication type:
- Article
Airway Epithelial miRNA Expression Is Altered in Asthma.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2012, v. 186, n. 10, p. 965, doi. 10.1164/rccm.201201-0027OC
- By:
- Publication type:
- Article
A randomized, placebo‐controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER).
- Published in:
- Clinical & Experimental Allergy, 2020, v. 50, n. 12, p. 1342, doi. 10.1111/cea.13731
- By:
- Publication type:
- Article
Preclinical Safety Profile of a Depleting Antibody against CRTh2 for Asthma: Well Tolerated Despite Unexpected CRTh2 Expression on Vascular Pericytes in the Central Nervous System and Gastric Mucosa.
- Published in:
- Toxicological Sciences, 2016, v. 152, n. 1, p. 72, doi. 10.1093/toxsci/kfw067
- By:
- Publication type:
- Article
Correction: Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors.
- Published in:
- PLoS ONE, 2017, v. 12, n. 10, p. 1, doi. 10.1371/journal.pone.0185862
- By:
- Publication type:
- Article